Arpeggio Biosciences, Inc. announced it raised $125,000 in an initial filing from an offering of $500,000

Company

Location

About

Arpeggio Biosciences is revolutionizing drug discovery by combining a proprietary biological assay with machine learning algorithms to generate rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots uncover the biological networks that drive a drug’s function, guiding more effective therapeutic development. Backed by a talented and diverse team, Arpeggio is dedicated to accelerating new treatments for patients with epigenetically-driven diseases.